KANGPU BIOPHARMACEUTICALS, LTD.
Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.
KANGPU BIOPHARMACEUTICALS, LTD.
Industry:
Biopharma Clinical Trials Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.kangpugroup.com
Total Employee:
11+
Status:
Active
Total Funding:
52.96 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS IIS
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Bioheng
Bioheng is a high-tech R&D innovation company.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Nagoya Institute of Clinical Pharmacology
Nagoya Institute of Clinical Pharmacology is a professional service company.
QnQuality Pharmaceuticals
QnQuality Pharmaceuticals is a drug R&D company.
Current Employees Featured
Fiona Du Chief Business Officer @ Kangpu Biopharmaceuticals, Ltd.
Chief Business Officer
Chuansheng Ge Founder, Chairman & Chief Executive Officer @ Kangpu Biopharmaceuticals, Ltd.
Founder, Chairman & Chief Executive Officer
Founder
Investors List
Shining Capital
Shining Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Zhongguancun Kaiyuan Capital
Zhongguancun Kaiyuan Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Lapam Capital
Lapam Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Yijing Capital
Yijing Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
ABC International
ABC International investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Ruihe Venture Capital
Ruihe Venture Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Furong Capital
Furong Capital investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Shenzhen Guozhong Venture Capital Management
Shenzhen Guozhong Venture Capital Management investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Official Site Inspections
http://www.kangpugroup.com
- Host name: ecs-119-3-105-187.compute.hwclouds-dns.com
- IP address: 119.3.105.187
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "Kangpu Biopharmaceuticals, Ltd."
About-Kangpu Biopharmaceuticals - KangpuGroup.com
Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for the treatment of autoimmune diseases, …See details»
Kangpu Biopharmaceuticals, Ltd. - Crunchbase …
Contact Email info@KangpuGroup.com Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for …See details»
Kangpu Biopharmaceuticals Profile and History - Datanyze
Www.kangpugroup.com Kangpu Biopharmaceuticals Profile and History Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and …See details»
Kangpu Biopharmaceuticals - VentureRadar
Website: https://www.kangpugroup.com/ Develops innovative small molecule treatments for solid tumors, hematological malignancies, auto-immune diseases, and ...See details»
Kangpu Biopharmaceuticals - PitchBook
Kangpu Biopharmaceuticals General Information Description. Opeartor of a clinical-stage company intended to focus on the discovery and development of …See details»
Kangpu Biopharmaceuticals Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kangpu Biopharmaceuticals Ltd. of Shanghai, Shanghai. Get the latest business insights from Dun & …See details»
领导团队-康朴生物医药官网 - KangpuGroup.com
程远远博士在卫生经济学、卫生技术评估、卫生政策分析等领域有近20年的工作经验。曾任职澳大利亚卫生部药品福利咨询委员会 (PBAC) 以及国际著名咨询公司 Covance、Optum 等，负责药品、医疗器械、以及诊断技术的市场准入战略 …See details»
Our Culture-Kangpu Biopharmaceuticals - KangpuGroup.com
868 Sichuan Road, Suite 401, Building B1, Yungu Innovation Park, Baohe District, Hefei, Anhui Province, China. Email: info@KangpuGroup.comSee details»
Kangpu Biopharmaceuticals
Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for the treatments of solid tumors, hematological …See details»
Company Profile-Kangpu Biopharmaceuticals - kangpugroup.com
Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for the treatment of autoimmune diseases, …See details»
康朴生物医药官网 - KangpuGroup.com
康朴生物医药是一家处于临床阶段的创新型生物医药企业。公司拥有一支实力雄厚、具有国际化视野和行业经验的创新药开发资深专家团队及运营团队。立足创新驱动，聚焦癌症、自身免疫疾 …See details»
Kangpu Biopharmaceuticals, Ltd. | LinkedIn
Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for the treatment of solid tumors, hematological …See details»
Kangpu Biopharmaceuticals Ltd. - Drug pipelines, Patents, Clinical ...
Apr 1, 2025 For more information, please visit www.KangpuGroup.com . SOURCE: Kangpu Biopharmaceuticals. Phase 1 IND Clinical Result Immunotherapy Phase 2. 03 Dec 2024 ...See details»
Kangpu Biopharmaceuticals Ltd. (康朴生物医药技术（合肥）有限 …
Apr 1, 2025 了解Kangpu Biopharmaceuticals Ltd. (康朴生物医药技术（合肥）有限公司)公司的药物管线，治疗领域，技术平台，以及它的5项临床试验, 15篇新闻，疾病领域:肿瘤，免疫系统 …See details»
Kangpu Biopharmaceuticals Received IND Approval from NMPA
Feb 26, 2025 HEFEI, China, Feb. 25, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. ("Kangpu") today announced that the Company has received IND approval from the CDE …See details»
Changzhou Kangpu Pharmaceutical Co Ltd. - Drug pipelines, …
Explore Changzhou Kangpu Pharmaceutical Co Ltd. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 2 news, Disease Domain:Endocrinology and Metabolic …See details»
康朴生物医药-动脉网 - vbdata.cn
Jan 19, 2011 tiane.wang@kangpugroup.com 康普生物制药有限公司是一家临床阶段公司，专注于发现和开发创新小分子，通过靶向蛋白质泛素化和靶向蛋白质泛素化等新一代解决方案治疗 …See details»
Kangpu Biopharmaceuticals - Overview, News & Similar
Mar 19, 2023 Who is Kangpu Biopharmaceuticals. Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for …See details»
Kangpu Biopharmaceuticals Received IND Approval from NMPA …
Feb 26, 2025 HEFEI, China I February 25, 2025 I Kangpu Biopharmaceuticals, Ltd. (“Kangpu”) today announced that the Company has received IND approval from the CDE (Center for Drug …See details»
康朴生物医药在美国完成NeoMIDES™分子胶KPG-818治疗系统性红 …
中国上海，2022年6月13日—康朴 生物医药 技术（上海）有限公司（“康朴生物医药”），一家处于临床阶段、致力于通过分子胶蛋白质泛素化降解等技术开发用于治疗癌症、自身免疫疾病、炎 …See details»